Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
|Articles|February 1, 2007
New devices modify noninvasive skin tightening
Approximately 94 percent of patients treated with the multiple pass/low fluence algorithm showed visible skin tightening at the time of treatment.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Pritelivir for Refractory Mucocutaneous HSV in Immunocompromised Adults
2
EADV 2026 Atopic Dermatitis Highlights: Tilrekimig, RAC2 Inhibition, and Level Up Data
3
Topical vs Oral JAK Inhibitors for Vitiligo: How to Choose as Systemic Options Advance
4
Don't Be Rash: Balancing Topical Steroids in the Era of Nonsteroidals
5